Advertisement
Advertisement
U.S. Markets open in 5 hrs 4 mins
S&P Futures
4,294.00 -4.25 (-0.10%) Dow Futures
33,880.00 +7.00 (+0.02%) Nasdaq Futures
13,659.75 -21.50 (-0.16%) Russell 2000 Futures
2,023.60 -0.20 (-0.01%) Crude Oil
88.19 -1.22 (-1.36%) Gold
1,773.30 -8.10 (-0.45%)
Horizon Therapeutics Public Limited Company (HZNP)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 67.47 |
| Open | 66.53 |
| Bid | 0.00 x 1300 |
| Ask | 0.00 x 900 |
| Day's Range | 64.76 - 66.84 |
| 52 Week Range | 60.76 - 120.54 |
| Volume | |
| Avg. Volume | 2,455,046 |
| Market Cap | 14.721B |
| Beta (5Y Monthly) | 1.16 |
| PE Ratio (TTM) | 27.57 |
| EPS (TTM) | 2.35 |
| Earnings Date | Feb 23, 2022 - Mar 02, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 137.50 |
- Investor's Business Daily
New Contender Viridian Takes Aim At Horizon's Eye Drug, And Rockets
Viridian unveiled promising results Monday for its Horizon-rivaling thyroid eye disease treatment — and the biotech stocks diverged.
- PR Newswire
Q32 Bio and Horizon Therapeutics Announce Collaboration in Autoimmune Diseases
Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, and Horizon Therapeutics plc (Nasdaq: HZNP), today announced that they have entered into a collaboration and option agreement to develop ADX-914 for the treatment of autoimmune diseases.
- Simply Wall St.
Some Analysts Just Cut Their Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) Estimates
One thing we could say about the analysts on Horizon Therapeutics Public Limited Company ( NASDAQ:HZNP ) - they aren't...
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
